Alessandro Lambiase Selected Research

Hyperemia

7/2022	Vernal keratoconjunctivitis activity induces decrease of ocular surface CD14, TLR-4 and TLR-9 expression.
5/2021	Treatment of Capecitabine Corneal Side Effects With Autologous Blood-derived Serum Eye Drops.
8/2011	Alterations of tear neuromediators in dry eye disease.
1/2011	Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis.
5/2007	Itchy-dry eye associated with polycystic ovary syndrome.
10/2006	Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy.
5/2003	Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Lambiase Research Topics

Disease

13	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2019 - 03/2003
12	Dry Eye Syndromes (Dry Eye Syndrome) 09/2020 - 02/2005
10	Keratitis 03/2022 - 10/2005
10	Inflammation (Inflammations) 03/2022 - 10/2003
8	Hypersensitivity (Allergy) 10/2019 - 01/2003
8	Glaucoma 01/2019 - 11/2008
7	Hyperemia 07/2022 - 05/2003
6	Infections 10/2021 - 10/2005
6	Pruritus (Itching) 01/2017 - 03/2003
6	Ulcer 07/2010 - 10/2006
5	Neoplasms (Cancer) 01/2022 - 08/2009
5	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 06/2005
5	Cataract (Cataracts) 01/2020 - 10/2003
5	Photophobia (Light Sensitivity) 01/2017 - 03/2003
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 08/2023 - 01/2016
4	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2022 - 03/2014
3	Corneal Diseases (Corneal Disease) 01/2022 - 07/2012
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2009
3	Asthma (Bronchial Asthma) 01/2022 - 05/2003
3	Fibrosis (Cirrhosis) 10/2021 - 10/2006
3	Limbal Stem Cell Deficiency 05/2021 - 09/2005
3	Corneal Injuries 05/2015 - 10/2006
3	Optic Nerve Diseases (Optic Neuropathy) 06/2011 - 11/2008
2	COVID-19 09/2022 - 10/2020
2	Hyperglycemia 01/2022 - 07/2020
2	Rhinosinusitis 01/2022 - 01/2021
2	Eye Diseases (Eye Disease) 10/2021 - 01/2015
2	Myopia 12/2020 - 01/2012
2	Melanoma (Melanoma, Malignant) 09/2020 - 01/2020
2	Ganglion Cysts (Ganglion) 05/2020 - 04/2019
2	Wounds and Injuries (Trauma) 04/2020 - 09/2014
2	Vision Disorders (Hemeralopia) 01/2018 - 01/2015
2	Retinal Degeneration 01/2017 - 01/2017
2	Foreign Bodies (Foreign Body) 01/2017 - 05/2003
2	Pain (Aches) 01/2017 - 10/2015
2	Keratoconus 06/2015 - 11/2005
2	Substance-Related Disorders (Drug Abuse) 05/2015 - 09/2014
2	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 01/2015 - 08/2011
2	Herpetic Keratitis 01/2014 - 01/2008
2	Rosacea (Acne Rosacea) 10/2013 - 09/2009
2	Corneal Ulcer 07/2010 - 07/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2010 - 12/2004
2	Ocular Hypertension (Glaucoma, Suspect) 12/2008 - 10/2005
1	Neurobehavioral Manifestations 04/2023
1	Graves Disease (Basedow Disease) 04/2023
1	Graves Ophthalmopathy 04/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Amyloidosis 01/2023
1	Atopic Dermatitis (Atopic Eczema) 03/2022
1	Conjunctivitis 03/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Obesity 01/2022

Drug/Important Bio-Agent (IBA)

44	Nerve Growth Factor (NGF)IBA 04/2023 - 10/2003
14	Retinaldehyde (Retinal)IBA 08/2023 - 11/2008
14	Ophthalmic Solutions (Eye Drops)IBA 01/2020 - 03/2003
8	Nerve Growth Factors (Neurotrophins)IBA 04/2023 - 10/2008
6	CytokinesIBA 07/2020 - 01/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 03/2014
5	AntibodiesIBA 10/2020 - 10/2003
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
4	NeuropeptidesIBA 10/2019 - 10/2008
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2011
4	SteroidsIBA 12/2018 - 07/2010
4	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2011 - 09/2005
3	Peptides (Polypeptides)IBA 01/2023 - 12/2006
3	Neuroprotective AgentsIBA 04/2019 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2020
2	Complement System Proteins (Complement)IBA 01/2022 - 04/2019
2	Therapeutic UsesIBA 12/2020 - 08/2009
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2019 - 12/2013
2	Endothelial Growth FactorsIBA 11/2018 - 01/2016
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2017 - 08/2011
2	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2016 - 01/2015
2	Doxycycline (Periostat)FDA LinkGeneric 10/2013 - 09/2009
2	Neuropeptide YIBA 01/2011 - 10/2008
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2011 - 10/2008
2	Substance PIBA 01/2011 - 10/2008
2	Matrix Metalloproteinases (MMPs)IBA 09/2009 - 08/2009
2	Metalloproteases (Metalloproteinases)IBA 09/2009 - 10/2003
2	Messenger RNA (mRNA)IBA 12/2006 - 10/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2006 - 10/2003
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2023
1	Amyloid beta-PeptidesIBA 01/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 09/2022
1	Secretory Immunoglobulin A (SIgA)IBA 09/2022
1	Immunoglobulin A (IgA)IBA 09/2022
1	BNT162 VaccineIBA 09/2022
1	Lipopolysaccharide ReceptorsIBA 07/2022
1	pimecrolimus (Elidel)FDA Link 03/2022
1	dupilumabIBA 03/2022
1	benralizumabIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022

Therapy/Procedure

14	Therapeutics 01/2022 - 07/2010
3	Slit Lamp 05/2021 - 01/2008
3	Aftercare (After-Treatment) 12/2020 - 03/2003
3	Vitrectomy 05/2020 - 04/2008
2	Drug Therapy (Chemotherapy) 05/2021 - 08/2009
2	Intravitreal Injections 04/2019 - 11/2018
2	Duration of Therapy 10/2013 - 11/2009